Citations

Showing 10 of 108135 citations.

The Relationship between Health Information Technology Laboratory Tracking Systems and Hospital Financial Performance and Quality
Zhao, Mei , Hamadi, Hanadi , Williams, Cynthia , Liu, Xinliang , Spaulding, Aaron , Spaulding, Aaron , Hamadi, Hanadi Y , Haley, D. Rob

Mayo Clinic

Hospital Topics | June 5, 2019 | Volume: 97 | Issue: 3 | Pages: 99-106

10.1080/00185868.2019.1623735 | PMID 31166151 Get It

Airway Innervation and Plasticity in Asthma
Kistemaker, Loes , Prakash, Y. S. , Prakash, Y S

Mayo Clinic

Physiology | June 5, 2019 | Volume: 34 | Issue: 4 | Pages: 283-298

10.1152/physiol.00050.2018 | PMID 31165683 Get It

Airway nerves represent a mechanistically and therapeutically important aspect that requires better highlighting in the context of diseases such as asthma. Altered structure and function (plasticity) of afferent and efferent airway innervation can contribute to airway diseases. We describe established anatomy, current understanding of how plasticity occurs, and contributions of plasticity to asthma, focusing on target-derived growth factors (neurotrophins). Perspectives toward novel treatment strategies and future research are provided.
Physiology in Perspective: The Dilemma of Muscle Weakness
Sieck, Gary C.

Mayo Clinic

Physiology | June 5, 2019 | Volume: 34 | Issue: 4 | Pages: 230-231

10.1152/physiol.00019.2019 | PMID 31165686 Get It

Prudence Using Serology to Determine Vaccine-Induced Immunity to Measles and Varicella in Patients With Inflammatory Bowel Disease
Rosh, Joel R. , Caldera, Freddy , Farraye, Francis A. , Hayney, Mary S.

Mayo Clinic

Inflammatory Bowel Diseases | June 5, 2019 | Volume: 25 | Issue: 9 | Pages: e113-e113

10.1093/ibd/izz106 | PMID 31165856 Get It

Electroencephalographic Reporting for Refractory Status Epilepticus
Sansevere, Arnold J. , Fernández, Iván Sánchez , Gaillard, William D. , Tasker, Robert C. , Lai, Yi‐Chen , Anderson, Anne E. , Tchapyjnikov, Dmitry , Chapman, Kevin , Brenton, J. Nicholas , Carpenter, Jessica L. , Gaínza‐Lein, Marina , Goldstein, Joshua , Goodkin, Howard P. , Jackson, Michele , Mikati, Mohamad A. , Peariso, Katrina , Topjian, Alexis , Wainwright, Mark S. , Williams, Korwyn, Loddenkemper, Tobias , Wilfong, Angus A. , Williams, Korwyn L, Brenton, J Nicholas , Tasker, Robert C , Tchapyjnikov, Dmitry , Wainwright, Mark S , Lai, Yi-Chen , Gaillard, William D , Mikati, Mohamad A , Loddenkemper, Tobias , Arya, Ravindra , Kapur, Kush , Glauser, Tracy A. , Abend, Nicholas S.

Mayo Clinic

Journal of Clinical Neurophysiology | June 5, 2019 | Volume: 36 | Issue: 5 | Pages: 365-370

10.1097/wnp.0000000000000595 | PMID 31166226 Get It

Purpose: We aimed to determine whether clinical EEG reports obtained from children in the intensive care unit with refractory status epilepticus could provide data for comparative effectiveness research studies. Methods: We conducted a retrospective descriptive study to assess the documentation of key variables within clinical continuous EEG monitoring reports based on the American Clinical Neurophysiology Society's standardized EEG terminology for children with refractory status epilepticus from 10 academic centers. Two pediatric electroencephalographers reviewed the EEG reports. We compared reports generated using free text or templates. Results: We reviewed 191 EEG reports. Agreement between the electroencephalographers regarding whether a variable was described in the report ranged from fair to very good. The presence of electrographic seizures (ES) was documented in 46% (87/191) of reports, and these reports documented the time of first ES in 64% (56/87), ES duration in 72% (63/85), and ES frequency in 68% (59/87). Reactivity was documented in 16% (31/191) of reports, and it was more often documented in template than in free-text reports (40% vs. 14%, P = 0.006). Other variables were not differentially reported in template versus free-text reports. Conclusions: Many key EEG features are not documented consistently in clinical continuous EEG monitoring reports, including ES characteristics and reactivity assessment. Standardization may be needed for clinical EEG reports to provide informative data for large multicenter observational studies.
Understanding the unmet sexual health needs of women with breast cancer
Kingsberg, Sheryl A. , Faubion, Stephanie S.

Mayo Clinic

Menopause | June 5, 2019 | Volume: 26 | Issue: 8 | Pages: 811-813

10.1097/gme.0000000000001372 | PMID 31166311 Get It

Defining certainty of net benefit: a GRADE concept paper
Alper, Brian S. , Oettgen, Peter, Kunnamo, Ilkka , Iorio, Alfonso , Ansari, Mohammed Toseef, Murad, M. Hassan , Meerpohl, Joerg J , Hultcrantz, Monica , Schünemann, Holger J. , Iorio, Alfonso , Murad, M Hassan , Meerpohl, Joerg J , Schünemann, Holger J , Ansari, Mohammed Toseef, Qaseem, Amir , Guyatt, Gordon , Alper, Brian S

Mayo Clinic

BMJ Open | June 5, 2019 | Volume: 9 | Issue: 6 | Pages: e027445

10.1136/bmjopen-2018-027445 | PMID 31167868 Get It

Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology is used to assess and report certainty of evidence and strength of recommendations. This GRADE concept article is not GRADE guidance but introduces certainty of net benefit, defined as the certainty that the balance between desirable and undesirable health effects is favourable. Determining certainty of net benefit requires considering certainty of effect estimates, the expected importance of outcomes and variability in importance, and the interaction of these concepts. Certainty of net harm is the certainty that the net effect is unfavourable. Guideline panels using or testing this approach might limit strong recommendations to actions with a high certainty of net benefit or against actions with a moderate or high certainty of net harm. Recommendations may differ in direction or strength from that suggested by the certainty of net benefit or harm when influenced by cost, equity, acceptability or feasibility.
OR19-6 A Novel Anti-CD40 Monoclonal Antibody, Iscalimab, Successfully Treats Graves’ Hyperthyroidism
Kahaly, George J. , Amer, Ahmed , Schuhmann, Imelda , Espié, Pascal, Rush, James S. , Basson, Craig T. , He, Yanling , Stan, Marius N. , Gergely, Péter Attila , Colin, Laurence , Amer, Ahmed

Mayo Clinic

Journal of the Endocrine Society | June 5, 2019 | Volume: 3 | Issue: Supplement_1 | Pages: No page available

10.1210/js.2019-or19-6 Get It

Carotid Cavernous Fistula Mimicking Hemicrania Continua: A Case Report
Fiebelkorn, Catherine Arnold, Chen, John J. , Brinjikji, Waleed , Eckel, Laurence J. , Arnold Fiebelkorn, Catherine, Boes, Christopher J. , Chen, John J , Lanzino, Giuseppe

Mayo Clinic

Headache: The Journal of Head and Face Pain | June 5, 2019 | Volume: 59 | Issue: 8 | Pages: 1365-1369

10.1111/head.13566 | PMID 31166017 Get It

Background Hemicrania continua is a primary headache disorder characterized by a continuous, unilateral headache associated with ipsilateral cranial autonomic features that responds to indomethacin. By definition, the symptoms are not referable to an underlying structural pathology. However, several cases of secondary hemicrania continua related to underlying structural lesions have been reported. Case We present a case of a 53‐year‐old male with a prolonged, right‐sided headache associated with intermittent right‐sided ptosis, conjunctival injection, tearing, and nasal congestion, suggestive of hemicrania continua, who was found to have an indirect carotid‐cavernous fistula, and who, after endovascular treatment of the fistula, had resolution of his symptoms. Conclusion Alternative, and perhaps less common, causes of headache should be considered when the clinical presentation is atypical or does not clearly fulfill diagnostic criteria for primary headache disorders. Carotid cavernous fistulas should be included within this differential, and represent a potentially treatable and reversible cause of otherwise refractory headache.
Adaptation and Validation of a Spanish version of the Treatment Burden Questionnaire in Patients with Multiple Sclerosis
Fiol, Marcela , Peña, Fernando Vázquez , Vanotti, Sandra, Ysrraelit, María Célica , Terrasa, Sergio , Tran, Viet-Thi , Montori, Víctor M. , Correale, Jorge Daniel

Mayo Clinic

No container title available | June 5, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.2.10092/v1 Get It

Abstract Background: The Treatment Burden Questionnaire (TBQ) is a self-reported measure of the effect of treatment workload on patient wellbeing. We sought to validate the TBQ in Spanish and use it to estimate the burden of treatment in Argentinian patients with multiple sclerosis (MS). Methods: The TBQ was forward-backward translated into Spanish. Two focus groups and 25 semi-structured interviews focused on wording and possible item exclusion. Validation was performed in 2 steps. First, 162 patients across a range of MS severity completed the questionnaire. Confirmatory factor analysis assessed the dimensional structure of the TBQ. Construct validity was assessed by studying correlations with fatigue and quality of life (QoL). Then, in a second cohort of 171 patients, we evaluated the association between TBQ scores and patients’ sex, age, education level, employment status, type of MS, disease duration, comorbidities, EDSS, pharmacological treatment and medication adherence. Results: The questionnaire presented a 3-factor structure in which burden was related to pharmacological treatment; comprehensive health assistance; and psycho-social-economic context. Composite reliability was > 0.8 for all factors. TBQ showed positive correlation with fatigue (rs= 0.467, p=0.006), negative correlation with QoL (rs -0.446, p=0.009). For the second cohort, total TBQ score was 43 (SD 29). Lowest scores were observed on self-monitoring (0.53, SD 1.3) and highest for administrative load (4.2, SD 3.4). Inverse association was found between the TBQ score and medication adherence (r 0.243 p=0.001). TBQ scores also correlated with daily patient pill/injection requirements (r 0.175 p=0.020). Individuals receiving injectable treatment scored higher than patients on oral drugs (total TBQ 51 (SD 32) vs 39 (SD 27) p=0.002). Conclusions: The TBQ in Spanish is a reliable instrument and showed adequate correlation with QoL and adherence scales in MS patients. TBQ may benefit health resources allocation and provide tailor therapeutic interventions to construct a minimally disruptive care.